EXPERIENCE WITH INTRAPERITONEAL CHEMOTHERAPY USING ASCITIC FLUID AS A SOLVENT OF CHEMICALS IN THE TREATMENT OF OVARIAN CANCER
Thirty two with the ascitic form of Stages IIIC—IV ovarian cancer underwent 1 to 3 courses of intraperitoneal multidrug therapy using a protein ascitic fluid concentrate (PAFC) as a solvent of drugs (cisplatin, cyclophosphan, doxorubicin) according to the CAP regimen. The induction chemotherapy allo...
Saved in:
Main Authors: | Yu. S. Sidorenko, G. A. Nerodo, A. P. Menshenina, L. Yu. Golotina, N. D. Ushakova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-09-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/301 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perspectives of pressurized intraperitoneal aerosol chemotherapy in terms of primary ovarian cancer with peritoneal carcinomatosis treatment
by: A. S. Dzasokhov, et al.
Published: (2023-03-01) -
The effect of Pressurised Intraperitoneal Aerosol Chemotherapy on the quality of life of patients with primary diagnosed ovarian cancer with peritoneal carcinomatosis during combined treatment
by: A. S. Dzasokhov, et al.
Published: (2023-03-01) -
Dynamic assessment of intraperitoneal aerosol chemotherapy under pressure impact on peritoneal carcinomatosis in ovarian cancer (immediate results)
by: A. S. Dzasokhov, et al.
Published: (2023-03-01) -
Ascitic ovarian cancer is an adequate preclinical model of carcinomatosis to study intraperitoneal chemoperfusion treatment
by: G. S. Kireeva, et al.
Published: (2019-02-01) -
Role of hyperthermic intraperitoneal chemotherapy in combination with an intraperitoneal port system in the treatment of patients with advanced ovarian cancer
by: V. V. Saevets, et al.
Published: (2022-01-01)